Ann: Mesoblast Type A Meeting with FDA, page-243

@madamswer

OH we UNDERSTAND the term madam!

We get it and always got it. The problem was relevance when a biotech stock was still in the emerging stages and there were - and remain - a number of financial options available.

Still you did a bang-up job of being an alarmist for instance, at the time of the Nasdaq listing oh the glory days!

Since then we have had a cluster of difficulties not least of which is the FDA. and for some reason you've decided it's time to pile in again.

Time for the long awaited burial? Your acolytes not succeeding as well as they might?

The problem you have is rumours of MSBs demise are GREATLY EXAGGERATED.

Still, you love making authoritative-sounding posts and your content is just formulaic and you are leaving behind - as much as is possible at your age - the turgid prose. Trying to sound pithy and meme-worthy....

Remember how often you'd exclaim the company was almost insolvent?

But then something would happen wouldn't it?

You'd post as if that was impossible. You continue to blast away with the equivalent of Abandon All Hope memes EVEN THOUGH you admit when MSB matures it has the capability of becoming a BEHEMOTH!

Some of us are onto you.

Finally coming to the AGM this year so you can be accountable or are you skipping out - yet again - for supposed safety reasons?